The National Tunisian Registry of Percutaneous Coronary Intervention is an observational, prospective and multicenter study aiming to assess coronary intervention strategies in tunisian departments of cardiology. Cardiologists from both sectors (public and private) are participating in the study, with 37 investigational centers. Data will be captured electronically by DACIMA Clinical Suite, according to FDA 21 CFR part 11 (Food and Drug Administration 21 Code of Federal Regulations part 11), HIPAA (Health Insurance Portability and Accountability Act) \& ICH (International Conference on Harmonisation) requirements.
Study Type
OBSERVATIONAL
Enrollment
2,698
Société Tunisienne de Cardiologie & de Chirurgie Cardiovasculaire
Tunis, Tunisia
MACE endopoint (Major adverse cardiovascular event)
Composite endpoint (MACE: major adverse cardiovascular event) : occurence of cardiovascular death, or non fatal myocardial infraction, or non fatal stroke, or Target Lesion revascularisation, or Target Vessel Revascularisation
Time frame: Time-To-Event measure up to 12 months from baseline
Death
Occurence of death incident (cardiovascular and non cardiovascular)
Time frame: Time-To-Event measure up to 12 months from baseline
PCI (Percutaneous Coronary Intervention)
PCI (Percutaneous Coronary Intervention) complications: any side effect event occuring per or post cardiac intervention
Time frame: Time-To-Event measure up to 12 months from baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.